Does Your Body Composition Affect Your Risk of Dementia or Parkinson’s?

People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer’s and Parkinson’s than people with low levels of fat in these areas, according to a study published in the July 24, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

حدد علماء مايو كلينك نوع جديد من فقدان الذاكرة لدى البالغين الأكبر سنًا

روتشستر، ولاية مينيسوتا — وضع الباحثون في مايو كلينك معايير جديدة لمتلازمة فقدان الذاكرة لدى البالغين الأكبر سنًا والتي تؤثر تحديدًا على الجهاز الحوفي الدماغي، وقد يتم تشخيص هذه الحالة على سبيل الخطأ على أنها داء الزهايمر في كثير من الأحيان. الخبر السار هو أن متلازمة التنكس العصبي لفقد الذاكرة السائدة الحوفي تتفاقم بصورة أبطأ ولها تنبؤات أفضل بخصوص سَيْر المرض، كما أصبحت محددة بشكل أوضح للأطباء الذين يعملون على إيجاد إجابات لمرضى فقدان الذاكرة.

UT Southwestern once again ranked best hospital in DFW

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.

Researchers Identify Potential Therapeutic Target for Management of Thirst Disorders

In a recent mouse-model study, published in Nature Neuroscience, researchers at University Hospitals (UH), Harrington Discovery Institute at UH, and Case Western Reserve University have now found that the cerebellum also controls thirst, a major function necessary for survival. Specifically, the research team found that a hormone, asprosin, crosses from the periphery into the brain to activate Purkinje neurons in the cerebellum. This leads to an enhanced drive to seek and drink water.

Study reveals racial disparities in Huntington’s disease diagnoses

New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.

Pilot Study Provides ‘Blueprint’ for Evaluating Diet’s Effect on Brain Health

Researchers from Johns Hopkins Medicine and the National Institutes of Health’s National Institute on Aging say their study of 40 older adults with obesity and insulin resistance who were randomly assigned to either an intermittent fasting diet or a standard healthy diet approved by the U.S. Department of Agriculture (USDA) offers important clues about the potential benefits of both eating plans on brain health.

Children’s Hospital Los Angeles Neurology Expert Available to Discuss FDA-Approved Gene Therapy Label Expansion for Patients with Duchenne Muscular Dystrophy

June 20, 2024 (Los Angeles) — Neurologist Leigh Ramos-Platt, MD, Medical Director of the Muscular Dystrophy Association Neuromuscular Clinic at Children’s Hospital Los Angeles (CHLA), is available to comment on the FDA expanded approval of gene therapy for patients with…

Study: Surgical Intervention Improves Quality of Life for Patients with Acoustic Neuroma

Researchers at University of California San Diego School of Medicine found that using an innovative surgical approach to remove an acoustic neuroma, a slow-growing, benign brain tumor, improved hearing preservation and quality of life for patients while also presenting excellent facial nerve outcomes.

Eating More Ultra-processed Foods Tied to Cognitive Decline, Stroke

People who eat more ultra-processed foods like soft drinks, chips and cookies may have a higher risk of having memory and thinking problems and having a stroke than those who eat fewer processed foods, according to a new study published in the May 22, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that eating ultra-processed foods causes memory and thinking problems and stroke. It only shows an association.

Early Alzheimer’s Detection with Artificial Intelligence

“AI-driven neuroimaging techniques have the potential to improve prediction models for Alzheimer’s progression and facilitate personalized treatment strategies,” says Domenico Praticò, MD, the Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple (ACT), at the Lewis Katz School of Medicine at Temple University (LKSOM).

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omeprazole and esomeprazole, histamine H2-receptor antagonists, or H2 blockers, such as cimetidine and famotidine, and antacid supplements.

Simulation reveals new mechanism for membrane fusion

An intricate simulation performed by UT Southwestern Medical Center researchers using one of the world’s most powerful supercomputers sheds new light on how proteins called SNAREs cause biological membranes to fuse.

Key to Unlocking the Secret of Degenerative Brain Disorders Found

A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae’s team from Pohang University of Science and Technology, has announced the development of a next-generation neuron labeling technology called NeuM.

Earlier Menopause Plus High Cardiovascular Risk May Lead to Cognitive Problems Later

Earlier menopause combined with higher risk of cardiovascular disease is linked to an increased risk of thinking and memory problems later, according to a new study published in the April 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. In this study, earlier menopause is defined as occurring before age 49.

UCLA Health neurologist receives award for innovative multiple sclerosis research

Dr. Rhonda Voskuhl, a professor of neurology at UCLA Health, has been awarded the 2024 John Dystel Prize for Multiple Sclerosis Research in recognition of her outstanding contributions to multiple sclerosis research and treatment.

Après une chirurgie de l’épilepsie : gérer les attentes et les soins

Avant la chirurgie, les personnes atteintes d’épilepsie subissent une longue évaluation et des tests approfondis. Mais après une opération chirurgicale, certains professionnels et défenseurs affirment que les gens sont injustement laissés seuls pour gérer le traitement et les soins, sans beaucoup d’aide ou de conseils.

Gene therapy offers hope for giant axonal neuropathy patients

A gene therapy developed by researchers at UT Southwestern Medical Center for a rare disease called giant axonal neuropathy (GAN) was well tolerated in pediatric patients and showed clear benefits, a new study reports. Findings from the phase one clinical trial, published in the New England Journal of Medicine, could offer hope for patients with this rare condition and a host of other neurological diseases.

Nerve decompression shows promise for diabetic neuropathy patients

Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.

Do Veterans Who Experience Concussions Have an Increased Risk of Alzheimer’s?

Middle-age veterans who experienced concussions due to blasts from explosive devices may have biomarkers in their spinal fluid similar to people who develop Alzheimer’s disease, according to a new study published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Black People Half as Likely to Be Evaluated for Genetic Testing as White People

Genetic testing has become a more common way to diagnose and manage many neurologic conditions including dementia, Parkinson’s disease and epilepsy, but a new study has found not everyone may have the same level of access to these tests. Black people were half as likely as white people to be evaluated for genetic testing, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Pediatric Neurologist Honored With Prestigious Research Award

Children’s Hospital Los Angeles (CHLA) neurologist Shafali Spurling Jeste, MD, has been named the 2024 recipient of the prestigious Martha Bridge Denckla Award from the Child Neurology Society. This award—named after a physician who pioneered the field of developmental cognitive neurology—honors physician-scientists of international standing who conduct research and clinical care focused on neurodevelopmental and neurobehavioral disorders.

“Talking about things that no one else will talk about”: Torie Robinson, host of Epilepsy Sparks Insights

Diagnosed with epilepsy at age 10, Torie Robinson uses her podcast to share knowledge with people with epilepsy, their families, and the public. Her episode topics range from the biochemistry of epilepsy to gastrointestinal issues and much, much more.

Gold nanoparticles reverse brain deficits in multiple sclerosis, Parkinson’s

Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson’s disease (PD) significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements.